Esperion Therapeutics Inc
Esperion Therapeutics Inc, located in Ann Arbor, MI, is a global biopharmaceutical company dedicated to advancing cardiovascular disease management through innovative treatments and collaborations. With two approved treatments in the US and Europe based on a unique mechanism of action, Esperion aims to broaden access to its medicines alongside various commercial partners.
The company's scientific team leads research in ACLY biology, positioning them at the forefront of therapeutic innovation. By utilizing cutting-edge discovery technologies and data science, Esperion strives to develop next-generation inhibitors that target multiple life-threatening diseases.
Generated from the website
Also at this address
Partial Data by Infogroup (c) 2025. All rights reserved.
